The head of Technology Management Department at College of Life Sciences - Kuwait University Dr. Bader S. AlEnezi received the patent registered under US 10,045,880 B2 from the US Patent Office for his invention, which is a continuous fever inhibitor.
On the field of invention, Dr. Bader AlEnezi stated that it is known that fever is an increase in the body's internal temperature to levels above normal by about 1-2 Celsius and vary according to the causes. However, since ancient times, humans have used various methods to reduce and treat fever, from the use of primitive methods such as compresses, until the science reached more advanced methods such as drugs like tablets or liquid medication, as well as some advanced silicon compresses He pointed out that despite this development, there are still disadvantages to these prescriptions, including the frequent use of chemicals in drugs, which have side effects, as well as short duration of the effect of compresses, which need great effort and continuous monitoring of the patient.
The new proposal introduces a new idea for a continuous fever reducing device that will reduce the use of medicines and reduce body temperature to normal and long lasting without the need for continuous monitoring, which will also reduce cost and effort. To treat more than one patient at the same time, as well as adaptability to use in the home, clinics and hospitals.
Dr. AlEnezi explained that the invention is a new technique aims at reducing the temperature of the fever by using a new device known as "continuous temperature reduction". This device includes several components, and it excels the traditional methods of treatment by: